Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is a valuable tool for diagnosing and managing hair and scalp disorders.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

The document concludes that various hair and scalp disorders in children have specific treatments and proper diagnosis is essential.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

The document concludes that understanding hair biology and recognizing hair conditions are crucial for managing and treating hair loss in children.

Hair transplants are effective for male and female pattern baldness, have evolved in technique, and require careful planning for natural results and managing complications.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Dianabol boosts muscle growth but has serious health risks and legal issues.

People with alopecia have a higher risk of thyroid cancer.

Electric Follicle Stimulation may promote hair growth and density with no known side effects.

A man developed a rare late-onset hair-pulling disorder, usually seen in younger people.

Stopping tight hairstyles can prevent and reduce traction alopecia.

The model and estimator can predict drug exposure in kidney transplant patients well.

Off-label drug use can be risky but sometimes beneficial when standard treatments fail.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.